1. Home
  2. SEPN vs XPER Comparison

SEPN vs XPER Comparison

Compare SEPN & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • XPER
  • Stock Information
  • Founded
  • SEPN 2022
  • XPER 1990
  • Country
  • SEPN United States
  • XPER United States
  • Employees
  • SEPN N/A
  • XPER N/A
  • Industry
  • SEPN
  • XPER Semiconductors
  • Sector
  • SEPN
  • XPER Technology
  • Exchange
  • SEPN NYSE
  • XPER Nasdaq
  • Market Cap
  • SEPN 453.2M
  • XPER 370.5M
  • IPO Year
  • SEPN 2024
  • XPER 2003
  • Fundamental
  • Price
  • SEPN $11.76
  • XPER $7.89
  • Analyst Decision
  • SEPN Strong Buy
  • XPER Strong Buy
  • Analyst Count
  • SEPN 5
  • XPER 3
  • Target Price
  • SEPN $26.75
  • XPER $19.00
  • AVG Volume (30 Days)
  • SEPN 443.6K
  • XPER 238.5K
  • Earning Date
  • SEPN 08-15-2025
  • XPER 08-04-2025
  • Dividend Yield
  • SEPN N/A
  • XPER N/A
  • EPS Growth
  • SEPN N/A
  • XPER N/A
  • EPS
  • SEPN N/A
  • XPER N/A
  • Revenue
  • SEPN $977,000.00
  • XPER $488,877,000.00
  • Revenue This Year
  • SEPN N/A
  • XPER $0.50
  • Revenue Next Year
  • SEPN $526.96
  • XPER $8.71
  • P/E Ratio
  • SEPN N/A
  • XPER N/A
  • Revenue Growth
  • SEPN 108.76
  • XPER N/A
  • 52 Week Low
  • SEPN $4.17
  • XPER $6.29
  • 52 Week High
  • SEPN $28.99
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • XPER 54.35
  • Support Level
  • SEPN N/A
  • XPER $7.90
  • Resistance Level
  • SEPN N/A
  • XPER $8.24
  • Average True Range (ATR)
  • SEPN 0.00
  • XPER 0.18
  • MACD
  • SEPN 0.00
  • XPER 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • XPER 70.08

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: